Author
Listed:
- Joseph S. Bednash
(Acute Lung Injury Center of Excellence, University of Pittsburgh, UPMC Montefiore)
- Nathaniel Weathington
(Acute Lung Injury Center of Excellence, University of Pittsburgh, UPMC Montefiore)
- James Londino
(Acute Lung Injury Center of Excellence, University of Pittsburgh, UPMC Montefiore)
- Mauricio Rojas
(Acute Lung Injury Center of Excellence, University of Pittsburgh, UPMC Montefiore)
- Dexter L. Gulick
(Acute Lung Injury Center of Excellence, University of Pittsburgh, UPMC Montefiore)
- Robert Fort
(Acute Lung Injury Center of Excellence, University of Pittsburgh, UPMC Montefiore)
- SeungHye Han
(Acute Lung Injury Center of Excellence, University of Pittsburgh, UPMC Montefiore)
- Alison C. McKelvey
(Acute Lung Injury Center of Excellence, University of Pittsburgh, UPMC Montefiore)
- Bill B. Chen
(Acute Lung Injury Center of Excellence, University of Pittsburgh, UPMC Montefiore)
- Rama K. Mallampalli
(Acute Lung Injury Center of Excellence, University of Pittsburgh, UPMC Montefiore
University of Pittsburgh
Medical Specialty Service Line, Veterans Affairs Pittsburgh Healthcare System)
Abstract
Inflammasomes regulate innate immune responses by facilitating maturation of inflammatory cytokines, interleukin (IL)-1β and IL-18. NACHT, LRR and PYD domains-containing protein 7 (NALP7) is one inflammasome constituent, but little is known about its cellular handling. Here we show a mechanism for NALP7 protein stabilization and activation of the inflammasome by Toll-like receptor (TLR) agonism with bacterial lipopolysaccharide (LPS) and the synthetic acylated lipopeptide Pam3CSK4. NALP7 is constitutively ubiquitinated and recruited to the endolysosome for degradation. With TLR ligation, the deubiquitinase enzyme, STAM-binding protein (STAMBP) impedes NALP7 trafficking to lysosomes to increase NALP7 abundance. STAMBP deubiquitinates NALP7 and STAMBP knockdown abrogates LPS or Pam3CSK4-induced increases in NALP7 protein. A small-molecule inhibitor of STAMBP deubiquitinase activity, BC-1471, decreases NALP7 protein levels and suppresses IL-1β release after TLR agonism. These findings describe a unique pathway of inflammasome regulation with the identification of STAMBP as a potential therapeutic target to reduce pro-inflammatory stress.
Suggested Citation
Joseph S. Bednash & Nathaniel Weathington & James Londino & Mauricio Rojas & Dexter L. Gulick & Robert Fort & SeungHye Han & Alison C. McKelvey & Bill B. Chen & Rama K. Mallampalli, 2017.
"Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity,"
Nature Communications, Nature, vol. 8(1), pages 1-13, August.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15203
DOI: 10.1038/ncomms15203
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15203. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.